IGF-1 Signaling

6th Nov 2026

MOLECULAR BIOLOGY • CELL SIGNALING • GROWTH FACTORS

IGF-1 Signaling: Pathway, Receptor Activation, Biological Functions and Research Applications

Explore insulin-like growth factor 1 signaling, IGF-1 receptor activation, PI3K/AKT and RAS/MAPK pathways, cell growth, survival, metabolism and cancer research.

1. Introduction to IGF-1 Signaling

Insulin-like growth factor 1 (IGF-1) is a peptide growth factor that plays an essential role in cellular growth, development, metabolism and tissue maintenance. It belongs to the insulin-like growth factor family and shares structural similarities with insulin.

IGF-1 exerts many of its biological effects through the insulin-like growth factor 1 receptor (IGF-1R), a transmembrane receptor tyrosine kinase expressed in numerous tissues.

When IGF-1 binds to IGF-1R, the receptor becomes activated and initiates intracellular signaling cascades. The two major downstream pathways are:

  • PI3K/AKT/mTOR signaling.
  • RAS/RAF/MEK/ERK signaling.

These pathways regulate several important biological processes, including:

  • Cell proliferation and growth.
  • Cell survival and apoptosis regulation.
  • Protein synthesis and metabolism.
  • Cell differentiation.
  • Development and tissue maintenance.
  • Cellular responses to nutrients and growth factors.
KEY SCIENTIFIC CONCEPT

IGF-1 signaling connects extracellular growth-factor stimulation to intracellular pathways controlling cell growth, survival and metabolism. Its biological effects depend on receptor availability, IGF-binding proteins, cell type and the surrounding signaling environment.

2. What Is Insulin-Like Growth Factor 1 (IGF-1)?

IGF-1 is a small peptide hormone and growth factor produced by multiple tissues. The liver is a major source of circulating IGF-1, particularly in response to growth hormone (GH), while many other tissues can produce IGF-1 locally.

IGF-1 acts through endocrine, paracrine and autocrine mechanisms:

  • Endocrine signaling: IGF-1 produced by one tissue enters the circulation and acts on distant target tissues.
  • Paracrine signaling: IGF-1 acts on neighboring cells within a tissue.
  • Autocrine signaling: Cells produce IGF-1 that acts on their own receptors.

IGF-1 and Growth Hormone

Growth hormone stimulates IGF-1 production, particularly in the liver. This relationship forms an important part of the growth hormone/IGF axis, which regulates postnatal growth and several metabolic processes.

However, local IGF-1 production and activity are also regulated independently of circulating growth hormone, depending on tissue and physiological conditions.

3. IGF-Binding Proteins (IGFBPs)

IGF-binding proteins are important regulators of IGF-1 availability and biological activity. Six major high-affinity IGF-binding proteins, IGFBP-1 through IGFBP-6, interact with IGF-1 and IGF-2.

These proteins regulate the distribution, transport, stability and interaction of IGFs with their receptors.

Main Functions of IGFBPs

  • Bind circulating IGF-1 and regulate its availability.
  • Protect IGF-1 from degradation.
  • Control the movement of IGFs between circulation and tissues.
  • Regulate the interaction between IGF-1 and IGF-1R.
  • Influence local IGF signaling in different tissue environments.

IGFBPs can either enhance or reduce IGF activity depending on their concentration, localization, proteolytic processing and interactions with the extracellular environment.

IMPORTANT DISTINCTION

IGFBPs are not simply inactive transport proteins. They actively influence IGF distribution and bioavailability, and some can also exert biological effects that are partly independent of IGF-1R.

4. Understanding the IGF-1 Receptor (IGF-1R)

IGF-1R is a member of the receptor tyrosine kinase family. It is structurally related to the insulin receptor and plays a central role in transmitting IGF-1 signals into the cell.

The mature IGF-1 receptor is a disulfide-linked heterotetramer composed of two extracellular alpha subunits and two beta subunits, commonly described as an α2β2 structure.

4.1 Alpha Subunits

The extracellular alpha subunits participate in ligand recognition and binding. They help determine the interaction between IGF-1 and the receptor.

4.2 Beta Subunits

The beta subunits contain transmembrane regions and intracellular tyrosine kinase domains. These domains are responsible for receptor phosphorylation and downstream signal initiation.

4.3 Receptor Activation

IGF-1 binding induces conformational changes in the receptor structure, promoting activation of its intracellular kinase domains and autophosphorylation of specific tyrosine residues.

These phosphorylation events create docking sites for adaptor proteins such as insulin receptor substrates (IRS-1 and IRS-2) and SHC, which connect IGF-1R to downstream signaling networks.

5. How Is the IGF-1 Signaling Pathway Activated?

5.1 IGF-1 Binding

IGF-1 binds to the extracellular region of IGF-1R. This interaction triggers structural rearrangements that activate the receptor.

5.2 Receptor Autophosphorylation

Activated IGF-1R phosphorylates tyrosine residues within its intracellular domains. This increases receptor kinase activity and creates binding sites for signaling proteins.

5.3 Adaptor Protein Recruitment

IRS proteins and SHC are major adaptor proteins involved in IGF-1R signaling.

Phosphorylated IRS proteins recruit PI3K-associated signaling components, while SHC can interact with GRB2 and SOS to activate RAS/MAPK signaling.

5.4 Activation of Downstream Pathways

These receptor-associated interactions initiate several intracellular cascades that regulate protein synthesis, metabolism, cell cycle progression and survival.

6. IGF-1 Signaling Pathway Diagram

The following simplified diagram illustrates the main steps of IGF-1-mediated signal transduction.

IGF-1 LIGAND

↓

IGF-1 RECEPTOR (IGF-1R)

↓

RECEPTOR AUTOPHOSPHORYLATION

↓

IRS-1 / IRS-2 / SHC RECRUITMENT

↓

MAJOR DOWNSTREAM PATHWAYS

PI3K → AKT → mTOR

RAS → RAF → MEK → ERK

↓

CELLULAR RESPONSES

Cell growth • Survival • Proliferation

Protein synthesis • Metabolism • Differentiation

7. PI3K/AKT/mTOR Signaling Pathway

The PI3K/AKT/mTOR pathway is one of the principal downstream signaling branches activated by IGF-1R. It plays a major role in regulating cell survival, metabolism, protein synthesis and cellular growth.

7.1 Activation of PI3K

Following IGF-1R activation, phosphorylated IRS proteins recruit the regulatory subunit of phosphoinositide 3-kinase (PI3K). This promotes PI3K activation.

PI3K converts phosphatidylinositol-4,5-bisphosphate (PIP2) into phosphatidylinositol-3,4,5-trisphosphate (PIP3) at the plasma membrane.

7.2 AKT Recruitment and Activation

PIP3 provides a membrane docking site for proteins containing pleckstrin homology domains, including AKT and PDK1.

AKT activation involves phosphorylation at key regulatory sites, including T308 by PDK1 and S473 through mTORC2-associated signaling.

7.3 mTOR Signaling

Activated AKT regulates mTOR-associated signaling, particularly mTOR complex 1 (mTORC1), which controls protein synthesis, nutrient responses and cell growth.

Important downstream targets include S6 kinase (S6K) and 4E-binding proteins (4E-BPs), which regulate translation and protein production.

7.4 Biological Effects

  • Promotes cell survival by regulating apoptosis-associated proteins.
  • Supports protein synthesis and cellular growth.
  • Regulates glucose metabolism and nutrient utilization.
  • Influences cell cycle progression.
  • Coordinates cellular responses to growth factors.

8. RAS/RAF/MEK/ERK Signaling Pathway

The RAS/MAPK pathway is another major branch of IGF-1R signaling. It is particularly important for regulating cell proliferation, differentiation and gene expression.

8.1 SHC and GRB2 Recruitment

Activated IGF-1R phosphorylates adaptor proteins such as SHC. Phosphorylated SHC recruits GRB2, which interacts with the guanine nucleotide exchange factor SOS.

8.2 RAS Activation

SOS promotes the exchange of GDP for GTP on RAS, converting it into its active form.

8.3 RAF and MEK Activation

Active RAS stimulates RAF kinases, which phosphorylate MEK1/2. Activated MEK subsequently phosphorylates ERK1/2.

8.4 ERK-Mediated Gene Regulation

Activated ERK can translocate into the nucleus and phosphorylate transcription factors and other regulatory proteins involved in cell cycle progression and gene expression.

Examples of downstream targets include ELK1, MYC and other transcriptional regulators, depending on cell type and signaling context.

9. Additional and Non-Canonical IGF-1 Signaling

Although PI3K/AKT and RAS/MAPK represent the best-characterized pathways, IGF-1R signaling is more complex and can involve additional intracellular mechanisms.

JAK/STAT Signaling

IGF-1R activity can interact with JAK/STAT signaling mechanisms, including STAT3 activation in selected cellular contexts. These interactions can influence gene expression, cell survival and proliferation.

JNK Signaling

IGF-1R can modulate c-Jun N-terminal kinase signaling. The outcome depends on the cellular environment and interactions with other stress-response pathways.

Receptor Internalization

After activation, IGF-1R can undergo internalization and intracellular trafficking. These processes influence receptor recycling, degradation and signal duration.

Cross-Talk with Other Receptors

IGF-1R can interact with other receptor systems and signaling networks. Such cross-talk allows cells to integrate growth-factor signals with additional environmental and physiological information.

10. Biological Functions of IGF-1 Signaling

10.1 Cell Growth and Proliferation

IGF-1 stimulates cellular growth through PI3K/AKT/mTOR and RAS/MAPK signaling. These pathways regulate protein synthesis, cell cycle progression and the expression of growth-associated genes.

10.2 Cell Survival and Apoptosis Regulation

IGF-1 can promote cell survival by activating AKT and regulating proteins involved in apoptosis. For example, AKT-mediated phosphorylation can reduce the pro-apoptotic activity of selected proteins.

10.3 Protein Synthesis and Metabolism

Through mTOR-associated mechanisms, IGF-1 signaling regulates protein synthesis and nutrient utilization. These functions are important for cellular growth and tissue maintenance.

10.4 Skeletal Muscle Biology

IGF-1 participates in skeletal muscle development, maintenance and repair. It can regulate muscle cell growth and influence satellite-cell activity in specific biological contexts.

10.5 Bone Growth and Development

IGF-1 contributes to bone formation and skeletal development by influencing osteoblast activity, matrix production and cellular differentiation.

10.6 Nervous System Development

IGF-1 is involved in neuronal development, differentiation and survival. Its signaling contributes to the regulation of nervous system growth and maintenance.

11. IGF-1 Signaling in Cancer Research

IGF-1R signaling has attracted considerable attention in cancer research because it regulates cell proliferation, survival and metabolism. Abnormal activation of this pathway may contribute to tumor development and progression in certain biological contexts.

11.1 Tumor Cell Proliferation

Increased IGF-1R signaling can activate RAS/MAPK and PI3K/AKT pathways, supporting the proliferation of tumor cells in susceptible models.

11.2 Resistance to Apoptosis

AKT-mediated survival signaling can reduce apoptosis and support the persistence of cells under stress or treatment conditions.

11.3 Tumor Metabolism

IGF-1 signaling influences glucose utilization, protein synthesis and other metabolic processes that may support tumor growth.

11.4 Therapeutic Resistance

Interactions between IGF-1R and other receptor tyrosine kinases may provide alternative survival signals and contribute to resistance mechanisms in some cancer models.

IMPORTANT RESEARCH NOTE

IGF-1R is not exclusively associated with cancer. It is essential for normal growth, metabolism and tissue maintenance. Its role in disease depends on tissue type, receptor expression, ligand availability and the wider molecular environment.

12. Regulation of IGF-1 Signaling

IGF-1 signaling is controlled by several regulatory mechanisms that influence ligand availability, receptor activity and downstream signal duration.

IGF-Binding Proteins

IGFBPs regulate IGF-1 distribution and receptor accessibility, influencing the intensity and duration of ligand-dependent signaling.

PTEN Regulation

Phosphatase and tensin homolog (PTEN) is a major negative regulator of PI3K/AKT signaling. It converts PIP3 back into PIP2, thereby reducing AKT recruitment and activation.

Feedback Regulation by mTOR/S6K

Activation of mTORC1 and S6K can trigger negative feedback mechanisms that reduce signaling through IRS proteins. This helps regulate pathway intensity and prevent excessive growth signaling.

Receptor Internalization and Degradation

IGF-1R can be internalized after ligand stimulation. Intracellular trafficking may result in receptor recycling or degradation, helping control receptor availability at the cell surface.

Phosphatases

Protein tyrosine phosphatases remove phosphate groups from receptor and adaptor proteins, contributing to the regulation and termination of signaling.

13. Laboratory Techniques to Study IGF-1 Signaling

Researchers use several molecular and biochemical methods to investigate IGF-1 expression, IGF-1R activation and downstream signaling activity.

13.1 Western Blotting

Western blotting is widely used to measure total and phosphorylated IGF-1R and downstream signaling proteins.

Common experimental targets include:

  • Phosphorylated IGF-1R.
  • Total IGF-1R.
  • Phosphorylated AKT and total AKT.
  • Phosphorylated ERK1/2 and total ERK1/2.
  • Phosphorylated S6 and S6K.
  • IRS-1 and IRS-2.

13.2 ELISA

ELISA can be used to quantify IGF-1 in serum, plasma, cell culture supernatants and other validated biological samples. Assay selection should account for IGF-binding proteins and sample preparation requirements.

13.3 RT-qPCR

Reverse transcription quantitative PCR allows researchers to evaluate IGF1, IGF1R, IGFBP and downstream gene expression changes.

13.4 Immunofluorescence

Immunofluorescence can be used to investigate receptor localization and the distribution of signaling proteins within cells.

13.5 Cell Proliferation Assays

Cell proliferation can be evaluated using validated metabolic or DNA-synthesis-based assays. These methods help determine how IGF-1 stimulation or pathway inhibition influences cell growth.

13.6 Apoptosis Assays

Apoptosis can be investigated using methods such as Annexin V staining, caspase activity measurements and analysis of apoptosis-associated proteins.

13.7 Phosphoproteomics

Phosphoproteomic analysis can identify phosphorylation changes across multiple proteins and reveal signaling interactions beyond the classical IGF-1 pathways.

EXPERIMENTAL TIP

When evaluating IGF-1R activation, compare phosphorylated receptor levels with total receptor abundance. Measuring downstream markers such as p-AKT and p-ERK provides additional evidence of pathway activity. Include appropriate controls and consider the time-dependent nature of growth-factor signaling.

14. Therapeutic Research Targeting IGF-1R

Because IGF-1R is involved in cellular growth and survival, it has been investigated as a potential therapeutic target in several diseases, particularly cancer.

Research approaches include:

  • Monoclonal antibodies targeting IGF-1R.
  • Small-molecule inhibitors of IGF-1R kinase activity.
  • Strategies targeting IGF ligand availability.
  • Combination approaches involving other signaling pathway inhibitors.
  • Biomarker studies to identify tumors dependent on IGF signaling.

However, therapeutic targeting has faced challenges, including metabolic effects, receptor cross-talk, compensatory signaling and differences in pathway dependence between tumor types.

Consequently, IGF-1R remains an important research subject, but its clinical relevance depends on careful molecular characterization and appropriate patient selection.

15. Conclusion

IGF-1 signaling is a central regulator of cellular growth, metabolism, survival and development. Through activation of IGF-1R, the growth factor initiates intracellular pathways that include PI3K/AKT/mTOR and RAS/RAF/MEK/ERK.

These pathways coordinate protein synthesis, cell cycle progression, metabolic activity and resistance to apoptosis. Their regulation involves IGF-binding proteins, phosphatases, receptor trafficking and feedback mechanisms.

Understanding the IGF-1 signaling network provides valuable insights into molecular biology, developmental processes, metabolic regulation, tissue maintenance and cancer research.

16. Frequently Asked Questions

What does IGF-1 stand for?

IGF-1 stands for insulin-like growth factor 1. It is a peptide growth factor involved in growth, development, metabolism and cell survival.

What is the receptor for IGF-1?

The main receptor is IGF-1R, a transmembrane receptor tyrosine kinase that activates intracellular signaling pathways following ligand binding.

Which pathways are activated by IGF-1?

The two major pathways are PI3K/AKT/mTOR and RAS/RAF/MEK/ERK. Additional signaling mechanisms may also be involved depending on the cell type.

What is the role of IRS-1 in IGF-1 signaling?

IRS-1 is an adaptor protein phosphorylated following IGF-1R activation. It helps recruit downstream signaling components, particularly those involved in PI3K/AKT signaling.

What is the function of IGFBPs?

IGF-binding proteins regulate IGF transport, stability, distribution and availability for receptor interaction.

How can IGF-1 signaling be measured?

Researchers commonly use Western blotting, ELISA, RT-qPCR, immunofluorescence, cell proliferation assays and phosphoproteomic techniques.

17. Scientific References and Further Reading

The following peer-reviewed publications provide detailed information about IGF-1, receptor activation, downstream signaling mechanisms and biological functions.

1. Choi, E., Duan, C., & Bai, X. (2025).

Regulation and function of insulin and insulin-like growth factor receptor signalling.

Nature Reviews Molecular Cell Biology, 26, 558–580.

Read scientific publication →
2. Werner, H. (2023).

The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities.

International Journal of Molecular Sciences, 24(19), 14882.

Read scientific publication →
3. Hakuno, F., & Takahashi, S. (2018).

IGF1 receptor signaling pathways.

Journal of Molecular Endocrinology, 61(1), T69–T86.

Read scientific publication →
4. The signaling landscape of insulin-like growth factor 1 (2025).

A review of canonical and non-canonical IGF-1 signaling mechanisms and their biological functions.

Journal of Biological Chemistry, 301(1), 108047.

Read scientific publication →

UNDERSTANDING IGF-1 SIGNALING

Growth Factors • Receptor Tyrosine Kinases • Molecular Biology